Login / Signup

Real-world data on the efficacy and safety of immune-checkpoint inhibitors in elderly patients with non-small cell lung cancer.

Daisuke MorinagaHajime AsahinaShotaro ItoOsamu HonjoHisashi TanakaRyoichi HondaHiroshi YokouchiKeiichi NakamuraKei TakamuraFumihiro HommuraYasutaka KawaiKenichiro ItoNoriaki SukohKeiki YokooRyo MoritaToshiyuki HaradaTaichi TakashinaTomohiro GodaHirotoshi Dosaka-AkitaHiroshi Isobenull null
Published in: Cancer medicine (2023)
ICI is also effective in elderly NSCLC patients, and treatment discontinuation due to irAEs may be a good prognostic marker.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • small cell lung cancer
  • prognostic factors
  • peritoneal dialysis
  • big data
  • middle aged
  • machine learning
  • artificial intelligence
  • tyrosine kinase
  • replacement therapy